These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 11165138)
1. Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues. Torres J; Navarro S; Roglá I; Ripoll F; Lluch A; García-Conde J; Llombart-Bosch A; Cervera J; Pulido R Eur J Cancer; 2001 Jan; 37(1):114-21. PubMed ID: 11165138 [TBL] [Abstract][Full Text] [Related]
2. Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus. Snaddon J; Parkinson EK; Craft JA; Bartholomew C; Fulton R Br J Cancer; 2001 Jun; 84(12):1630-4. PubMed ID: 11401316 [TBL] [Abstract][Full Text] [Related]
3. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome. Panigrahi AR; Pinder SE; Chan SY; Paish EC; Robertson JF; Ellis IO J Pathol; 2004 Sep; 204(1):93-100. PubMed ID: 15307142 [TBL] [Abstract][Full Text] [Related]
4. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387 [TBL] [Abstract][Full Text] [Related]
5. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390 [TBL] [Abstract][Full Text] [Related]
6. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Dahia PL; Aguiar RC; Alberta J; Kum JB; Caron S; Sill H; Marsh DJ; Ritz J; Freedman A; Stiles C; Eng C Hum Mol Genet; 1999 Feb; 8(2):185-93. PubMed ID: 9931326 [TBL] [Abstract][Full Text] [Related]
7. Functional definition of relevant epitopes on the tumor suppressor PTEN protein. Andrés-Pons A; Valiente M; Torres J; Gil A; Roglá I; Ripoll F; Cervera J; Pulido R Cancer Lett; 2005 Jun; 223(2):303-12. PubMed ID: 15896465 [TBL] [Abstract][Full Text] [Related]
8. Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas. Qiao J; Kang J; Cree J; Evers BM; Chung DH Ann Surg; 2005 May; 241(5):684-91; discussion 691-2. PubMed ID: 15849504 [TBL] [Abstract][Full Text] [Related]
9. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover. Maehama T; Okahara F; Kanaho Y Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605 [TBL] [Abstract][Full Text] [Related]
10. Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells. Ginn-Pease ME; Eng C Cancer Res; 2003 Jan; 63(2):282-6. PubMed ID: 12543774 [TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720 [TBL] [Abstract][Full Text] [Related]
12. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN. Gray IC; Stewart LM; Phillips SM; Hamilton JA; Gray NE; Watson GJ; Spurr NK; Snary D Br J Cancer; 1998 Nov; 78(10):1296-300. PubMed ID: 9823969 [TBL] [Abstract][Full Text] [Related]
13. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505 [TBL] [Abstract][Full Text] [Related]
14. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN. Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086 [TBL] [Abstract][Full Text] [Related]
15. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703 [TBL] [Abstract][Full Text] [Related]
18. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603 [TBL] [Abstract][Full Text] [Related]
19. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Di Vizio D; Cito L; Boccia A; Chieffi P; Insabato L; Pettinato G; Motti ML; Schepis F; D'Amico W; Fabiani F; Tavernise B; Venuta S; Fusco A; Viglietto G Oncogene; 2005 Mar; 24(11):1882-94. PubMed ID: 15674339 [TBL] [Abstract][Full Text] [Related]
20. PTEN and myotubularin: novel phosphoinositide phosphatases. Maehama T; Taylor GS; Dixon JE Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]